Skip to content

Pharmacy

CVS announces organizational changes

CVS announces organizational changes

CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone.

BD launches ergonomic pen needle technology

BD launches ergonomic pen needle technology

BD (Becton, Dickinson and Company), announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano pen needle, designed for more reliable subcutaneous injection depth.

Aurobindo receives FDA approval for dofetilide capsules

Aurobindo receives FDA approval for dofetilide capsules

Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Dofetilide Capsules, 0.125 mg, 0.25 mg, and 0.5 mg. Aurobindo’s dofetilide capsules are an AB-rated generic equivalent to the reference listed drug, Pfizer’s Tikosyn.

Walgreens issues statement on settlement

Walgreens issues statement on settlement

DEERFIELD, Ill. – Walgreens has issued the following statement on announced settlement with U.S. Department of Justice and the Office of the Inspector General of the U.S. Department of Health and Human Services: “Walgreens is pleased to have resolved these matters with the Department of Justice.

Walgreens settles two lawsuits

Walgreens settles two lawsuits

Walgreens Boots Alliance has agreed to pay more than $269 million to settle federal and state lawsuits that accused the retailer of overbilling federal health-care programs. The pharmacy chain will pay $209.

CVS Health honored for 5th time in a row by Fortune magazine

CVS Health honored for 5th time in a row by Fortune magazine

CVS Health today was recognized by Fortune magazine as one of the World’s Most Admired Companies for the fifth consecutive year. CVS Health was honored as No. 35 on the annual rankings of the world’s most respected and reputable corporations, up four spots from 2018. The company was also ranked No.

Government shutdown having major effect on FDA

Government shutdown having major effect on FDA

The U.S. Food and Drug Administration has roughly five weeks of funding left to review new drug applications during the shutdown, commissioner Dr. Scott Gottlieb reported this past week on Twitter.